APA

Russell-Jones R., Powell A., Acland K., Calonje E., O'Doherty M. & Healy C. (20050628). The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB). : European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Chicago

Russell-Jones R, Powell A-M, Acland K, Calonje E, O'Doherty M and Healy C. 20050628. The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB). : European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Harvard

Russell-Jones R., Powell A., Acland K., Calonje E., O'Doherty M. and Healy C. (20050628). The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB). : European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

MLA

Russell-Jones R, Powell A-M, Acland K, Calonje E, O'Doherty M and Healy C. The chances of a patient with melanoma developing in transit disease are doubled by undergoing sentinel lymph node biopsy (SLNB). : European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 20050628.